APEX MEDICAL LIMITED

Apex Medical Group Limited (referred as 'Apex') is a leading provider for health screening and testing services via our accredited laboratories. Apex is a leading Pre-IPO biotech company that has been revolutionising the field since its inception in 2018, providing clinical diagnostic laboratory testing services to doctors, insurance and medical institutions. Apex Medical carefully selects quality products from established suppliers within the healthcare market worldwide. Apex represents Nox in New Zealand and Medikro in New Zealand, as well as the e-Chamber asthma spacer range and Nonin. The company's early breakthrough came with the successful extraction of cffDNA, marking a significant advancement in non-invasive prenatal testing. In 2021, “Apex” further expanded its expertise into the realm of reproductive medicine. Always at the forefront of innovation, “Apex” continued to push the boundaries of biotechnology in 2023 by venturing into artificial intelligence (AI) research.